HTEC vs. CNCR

Last updated Jun 4, 2026

HTEC (ROBO Global Healthcare Technology and Innovation ETF) and CNCR (Loncar Cancer Immunotherapy ETF) are both Health & Biotech Equities funds from Exchange Traded Concepts - HTEC tracks the ROBO Global® Healthcare Technology and Innovation Index while CNCR tracks the Loncar Cancer Immunotherapy Index. Both are passively managed. HTEC charges 0.68%/yr vs 0.79%/yr for CNCR.

Performance

HTEC vs. CNCR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ROBO Global Healthcare Technology and Innovation ETF (HTEC) and Loncar Cancer Immunotherapy ETF (CNCR). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

HTEC

• 1D: 0.67%
• 1M: 3.12%
• YTD: -2.96%
• 6M: -3.90%
• 1Y: 26.68%
• 3Y*: 5.17%
• 5Y*: -4.88%
• 10Y*: —

CNCR

• 1D: 0.00%
• 1M: 0.00%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

HTEC vs. CNCR - Yearly Performance Comparison

	2026 (YTD)
HTEC ROBO Global Healthcare Technology and Innovation ETF	-3.72%
CNCR Loncar Cancer Immunotherapy ETF	0.00%

HTEC vs. CNCR - Sectors Allocation Comparison

Sectors	HTEC	CNCR
Healthcare	77.3%	96.6%
Financial Services	3.9%	3.3%
Technology	3.7%	-
Industrials	1.3%	-
Energy	1.2%	-
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Real Estate	-	-
Utilities	-	-

Return for Risk

HTEC vs. CNCR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HTEC

HTEC Risk / Return Rank: 34
HTEC Sharpe Ratio Rank: 36
HTEC Sortino Ratio Rank: 38
HTEC Omega Ratio Rank: 33
HTEC Calmar Ratio Rank: 33
HTEC Martin Ratio Rank: 29

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HTEC vs. CNCR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ROBO Global Healthcare Technology and Innovation ETF (HTEC) and Loncar Cancer Immunotherapy ETF (CNCR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	HTEC	CNCR	Difference
Sharpe ratio: Return per unit of total volatility	1.32	—	—
Sortino ratio: Return per unit of downside risk	1.99	—	—
Omega ratio: Gain probability vs. loss probability	1.23	—	—
Calmar ratio: Return relative to maximum drawdown	1.64	—	—
Martin ratio: Return relative to average drawdown	4.07	—	—
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

Sharpe Ratios by Period

	HTEC	CNCR	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.32	—	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.20	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.21	—	—

Drawdowns

HTEC vs. CNCR - Drawdown Comparison

The maximum HTEC drawdown since its inception was -57.53%, which is greater than CNCR's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for HTEC and CNCR.

Drawdown Indicators

	HTEC	CNCR	Difference
Max Drawdown Largest peak-to-trough decline	-57.53%	0.00%	-57.53%
Max Drawdown (1Y) Largest decline over 1 year	-16.31%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-28.67%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-56.10%	—	—
Current Drawdown Current decline from peak	-33.25%	0.00%	-33.25%
Average Drawdown Average peak-to-trough decline	-28.99%	0.00%	-28.99%
Ulcer Index Depth and duration of drawdowns from previous peaks	6.57%	—	—

Volatility

Volatility by Period

	HTEC	CNCR	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.82%	—	—
Volatility (6M) Calculated over the trailing 6-month period	14.90%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	20.32%	0.00%	+20.32%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	24.39%	0.00%	+24.39%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	25.46%	0.00%	+25.46%

HTEC vs. CNCR - Expense Ratio Comparison

HTEC has a 0.68% expense ratio, which is lower than CNCR's 0.79% expense ratio.

Dividends

HTEC vs. CNCR - Dividend Comparison

HTEC's dividend yield for the trailing twelve months is around 1.01%, while CNCR has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021
CNCR Loncar Cancer Immunotherapy ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
HTEC ROBO Global Healthcare Technology and Innovation ETF	1.01%	0.98%	0.00%	0.00%	0.00%	0.05%

Frequently Asked Questions

Which ETF is better, HTEC or CNCR?

On fees, HTEC is cheaper at 0.68% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, HTEC or CNCR?

HTEC is cheaper with a 0.68% expense ratio, compared with 0.79% for CNCR.

Which ETF pays a higher dividend yield, HTEC or CNCR?

HTEC has the higher dividend yield at 1.01%, compared with 0.00% for CNCR.

What is the main difference between HTEC and CNCR?

HTEC tracks ROBO Global® Healthcare Technology and Innovation Index, while CNCR tracks Loncar Cancer Immunotherapy Index. Their fees differ too: 0.68% for HTEC and 0.79% for CNCR.